Skip to main content
. 2018 May 9;150(1):65–73. doi: 10.1093/ajcp/aqy032

Table 3.

Survival Analysis for Clinical Characteristics of the Patients

Parameter No. of Patients OS, mo RFS, mo
Mean (SD) P Value Mean (SD) P Value
Age, y
 ≤59 186 83.5 (2.3) .771 69.0 (3.0) .151
 >59 170 82.8 (2.3) 60.6 (3.2)
Sex
 Male 140 77.9 (2.9) .021 57.6 (3.5) .009
 Female 216 86.9 (1.8) 70.2 (2.7)
pT
 1 205 90.1 (1.6) <.001 74.6 (2.6) <.001
 2 138 76.9 (3.0) 55.3 (3.6)
 3 10 31.3 (6.0) 17.2 (5.1)
 4 3 38.5 (9.0) 14.5 (5.0)
pN
 0 259 90.9 (1.3) <.001 77.3 (2.2) <.001
 1 24 62.4 (5.3) 36.6 (6.3)
 2 73 60.0 (4.6) 28.8 (3.3)
 3
Stages
 1 251 91.7 (1.3) <.001 79.2 (2.2) <.001
 2 27 64.1 (5.2) 34.3 (6.0)
 3 78 59.0 (4.5) 28.0 (3.0)
Location
 Left lobes 145 86.7 (2.3) .147 69.0 (3.4) .274
 Right lobes 211 81.2 (2.2) 62.8 (2.9)
Tumor size
 Small (≤20 mm) 182 90.8 (1.6) <.001 77.1 (2.6) <.001
 Large (>20 mm) 174 74.0 (2.7) 51.8 (3.2)
Smoking
 Nonsmoker 258 86.1 (1.8) .028 69.3 (2.5) .009
 Current/ex-smoker 98 74.3 (3.4) 53.8 (4.0)
Operation
 Partial resection 24 73.3 (2.9) .469 73.1 (3.0) .028
 Segmentectomy 7 54.0 (6.4) 38.2 (9.6)
 Lobectomy or more 325 83.4 (1.7) 64.3 (2.3)
Lymph/vascular invasion
 No 266 89.3 (1.5) <.001 75.2 (2.3) <.001
 Yes 90 64.5 (4.0) 35.5 (3.8)

OS, overall survival; RFS, recurrence-free survival.